BIGNOPE
Ko-fi

Recalls affecting Massachusetts

Data last updated: September 7, 2026 at 12:15 AM UTC

16,837 recalls found

Just announced

Straight from FDA press releases — not yet formally classified or risk-graded
UnclassifiedUndeclaredAnnounced September 4, 2026

Business Pill, Branch Manager for Mendietary supplements marketed for male sexual enhancement

Products contain undeclared yohimbine

Full report
Dietary SupplementsFood & Beverages

Recalling firm: SUPPLX.com

Grant-Valkaria, Florida - SUPPLX.com is voluntarily recalling Business Pill and Branch Manager for Men, products marketed as dietary supplements for male sexual enhancement, because FDA laboratory analysis confirmed that both products contain yohimbine that is not declared on the product labels.

Company contact: (321) 341-9501 · SupplxRecall@gmail.com

View FDA’s announcement (opens in a new tab)
UnclassifiedBacteria/virusAnnounced September 4, 2026

Foods AliveMoringa Leaf Powder

Potential to be contaminated with Salmonella

Full report
Food & BeveragesFoodborne Illness

Recalling firm: Foods Alive Inc.

Foods Alive Inc of Angola, IN, is recalling its 8-ounce packages of organic moringa leaf powder because they have the potential to be contaminated with Salmonella , an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.

View FDA’s announcement (opens in a new tab)
UnclassifiedAnnounced September 3, 2026

B. Braun0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container

Presence of particulate matter identified as iron oxide

Full report
Drugs

Recalling firm: B. Braun Medical Inc.

“On September 3, 2026 firm updated their press release to include additional contaminants.” FOR IMMEDIATE RELEASE – September 3, 2026– Bethlehem, PA, B. Braun Medical Inc (B. Braun) is voluntarily recalling three (3) lots of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container, to the hospital/healthcare facility/user level due to presence of particulate matter identified as iron…

Company contact: recalls@bbraunusa.com

View FDA’s announcement (opens in a new tab)
UnclassifiedBacteria/virusAnnounced September 3, 2026

Great ValueOrganic Triple Berry Blend

Possible E. Coli Contamination

Full report
Food & BeveragesFoodborne Illness

Recalling firm: Frutas y Hortalizas del Sur S.A.

September 02, 2026. Frutas y Hortalizas del Sur S.A., San Carlos, Chile expands its July 3, 2026, recall of frozen organic IQF blueberries to include one lot of Great Value frozen Organic Triple Berry Blend 10 OZ because of potential contamination with Escherichia coli O145:H28 (E. coli O145) .

Company contact: Info.foodsafety@comfrut.com

View FDA’s announcement (opens in a new tab)
UnclassifiedAnnounced September 3, 2026

American Regent, Inc.Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) multi dose vial

Presence of particulate matter and lack of sterility assurance

Full report
Food & Beverages

Recalling firm: American Regent, Inc.

FOR IMMEDIATE RELEASE – September 3, 2026 – New Albany, OH, American Regent, Inc. is conducting a nationwide voluntary recall of three lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) multi dose vials to the consumer level. Customer complaints were received for leaking and cracked vials, resulting in lack of assurance of sterility.

View FDA’s announcement (opens in a new tab)
UnclassifiedUndeclaredAnnounced August 31, 2026

LipofitLipofit Extreme 2.0 Fat Burner Dietary Supplement

Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)

Full report
Dietary SupplementsDrugs

Recalling firm: Ana Salazar Modela Tu Cuerpo Inc.

FOR IMMEDIATE RELEASE - August 27, 2026 - Davie, Florida – Ana Salazar Modela Tu Cuerpo Inc. is recalling Lipofit Extreme Fat Burner 2.0, Lot 25M12F, expiration date 09/2027, to the consumer level.

Company contact: (954) 305-1004 · yandrydy@gmail.com

View FDA’s announcement (opens in a new tab)
UnclassifiedAnnounced August 31, 2026

KofinasGarlic Mediterranean Infused Extra Virgin Olive Oil 500 ml, 250 ml, and 100 ml

Contains garlic essential oil not approved for culinary use

Full report
Food & BeveragesIngredients

Recalling firm: LMSI LLC

Cincinnati, OH (Aug. 29, 2026) - LMSI LLC/ Kofinas Olive Oil is issuing a voluntary recall of its Garlic Mediterranean infused extra virgin olive oil for using a garlic essential oil not approved for culinary use. The flavored oil was bottled in glass bottles in 500 ml, 250 ml, and 100 ml sizes.

View FDA’s announcement (opens in a new tab)
UnclassifiedAllergenUndeclaredAnnounced August 31, 2026

Little TemptationsChocolatey Eyeballs, 7 oz., 10 oz., 10.5 oz., 11 oz., and 16 oz.

Undeclared milk

Full report
Food & BeveragesAllergens

Recalling firm: Crystal Temptations

Crystal Temptations of North Arlington, NJ is recalling Halloween Chocolatey Eyeballs because they contain undeclared MILK allergens. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume these products.

View FDA’s announcement (opens in a new tab)
UnclassifiedBacteria/virusAnnounced August 29, 2026

Everything SproutsRobust Radish Mix, 5oz Cups

Potential to be contaminated with Shiga toxin-producing Escherichia coli (STEC) or Salmonella.

Full report
Food & BeveragesFoodborne Illness

Recalling firm: Everything Sprouts, LLC

Everything Sprouts, LLC, based in Minneapolis, MN is expanding its voluntary recall of sprouts to include certain lots of Robust Radish Sprout Mix because it has the potential to be contaminated with Shiga toxin producing Escherichia coli (STEC) or Salmonella bacteria.

Company contact: everythingsproutsmn@gmail.com

View FDA’s announcement (opens in a new tab)
UnclassifiedBacteria/virusAnnounced August 29, 2026

MartinaMangoes

Potential contamination with Salmonella

Full report
Food & BeveragesFoodborne Illness

Recalling firm: Panorama Produce

MAMARONECK, NY, AUG. 28, 2026 - Panorama Produce is recalling 302 boxes of size 9 (nine) mangoes because they may be contaminated with Salmonella , an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.

Company contact: information@panoramaproduce.com

View FDA’s announcement (opens in a new tab)
Wording
Class IIModerate risk
DrugRecalled May 29, 2013

Stanozolol (50 mg/ml and 100 mg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-783-2013
Lot/product code:
50mg/ml = Lots B5727 Exp 8/27/13, and C5708 Exp 9/8/13 // 100,g/ml =Lot C5706 Exp 9/6/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Guanabenz 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-738-2013
Lot/product code:
A0422 Exp 7/31/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Detomidine 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-717-2013
Lot/product code:
C5505 Exp 9/5/13 and C5107 Exp 9/7/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Acepromazine 25 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-693-2013
Lot/product code:
B0112 exp 08/31/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Caco/Copper 6. 2 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-709-2013
Lot/product code:
L5610 exp 11/30/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Fluphenazine 25 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-729-2013
Lot/product code:
C5428 Exp 9/4/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Ketamine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-745-2013
Lot/product code:
B3411 Exp 8/11/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Altrenogest 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-696-2013
Lot/product code:
L5012 exp. 11/30/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

HACC 270.1 Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-739-2013
Lot/product code:
C0321 Exp 9/3/13 and B5627 6/4/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Idoxuridine 0.1% Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-742-2013
Lot/product code:
L5703 Exp 11/30/2013
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Detomidine w/Xylazine 100 mg/mg Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-718-2013
Lot/product code:
A5125 Exp 12/31/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Pento-Gluc 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-767-2013
Lot/product code:
B0521 Exp 8/21/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Metabolase Forte Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-753-2013
Lot/product code:
B5021 Exp 9/30/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Methylcobalamin P 10/ml Creatine 40 mg/ml / Arginine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-755-2013
Lot/product code:
B0001 Exp 8/1/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Phentolamine 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-770-2013
Lot/product code:
B31012 Exp 8/31/13, B5102 Exp 8/10/13, C5228 Exp 9/22/13, B5012 Exp 12/31/13, and C5111 exp 9/11/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Gentamicin 300 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-733-2013
Lot/product code:
B5014 Exp 8/13/13 and C3913 Exp 9/9/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Dextrose 50% Solution, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-721-2013
Lot/product code:
A5414 Exp 12/31/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Deslorelin 15 mg vial, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-716-2013
Lot/product code:
A3021 Exp 6/2/13 and L5011 exp 12/11/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Testosterone Cypionate (100 mg/ml & 200 mg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-786-2013
Lot/product code:
A5016 Exp 12/31/13 and B5028 6/5/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Diphenhydramine 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-723-2013
Lot/product code:
A3804 Exp 12/31/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Phenobarbital 62. 5mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-769-2013
Lot/product code:
B5128 Exp 8/28/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Phenylephrine 1 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-772-2013
Lot/product code:
L5017 Exp 10/31/13, C51301 Exp 9/30/13, B5312 Exp 8/31/13, and A5209 Exp 11/01/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Cal-Phos 1000 Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-711-2013
Lot/product code:
A5211 Exp 12/31/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Sodium Tetradecyl Sulfate (0.125%, 1%, 2.5%, 3%, and 4%) Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-782-2013
Lot/product code:
0.125% Lot B3505 Exp 8/1/13 // 1% Lots C5001 Exp 9/30/13, C5406 Exp 9/4/13, and C5306 Exp 9/30/13 // 2.5% Lot C5101 Exp 9/30/13 // 3% Lots B5120 Exp 10/31/13, C5301 Exp 9/30/13, B5428 Exp 6/4/13, and C5212 Exp 9/21/13 // 4% Lot C5301 Exp 9/30/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Gentamicin 0.3% Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-732-2013
Lot/product code:
A5308 Exp 6/30/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)